These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20719217)

  • 21. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA; Barley J
    Sex Transm Dis; 2009 Jan; 36(1):58-62. PubMed ID: 18830138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human papillomavirus vaccine acceptability among a national sample of adult women in the USA.
    Stupiansky NW; Rosenthal SL; Wiehe SE; Zimet GD
    Sex Health; 2010 Sep; 7(3):304-9. PubMed ID: 20719219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM; Kaldor JM; Garland SM
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human papillomavirus vaccine introduction in Vietnam: formative research findings.
    Nghi NQ; Lamontagne DS; Bingham A; Rafiq M; Mai le TP; Lien NT; Khanh NC; Hong DT; Huyen DT; Tho NT; Hien NT
    Sex Health; 2010 Sep; 7(3):262-70. PubMed ID: 20719213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination.
    Budd AC; Sturrock CJ
    Sex Health; 2010 Sep; 7(3):328-34. PubMed ID: 20719223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Implementation of HPV vaccination in Germany].
    Schreckenberger C; Kaufmann AM; Schneider A
    Dtsch Med Wochenschr; 2007 Oct; 132(42):2221-4. PubMed ID: 17926251
    [No Abstract]   [Full Text] [Related]  

  • 27. [Vaccines against human papillomavirus (HPV); between registration and implementation].
    van Rossum TG; de Melker HE; Houweling H; Voordouw AC; Meijer CJ; Helmerhorst TJ; Kretzschmar M; Berkhof J; van der Noordaa J
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):987-92. PubMed ID: 18549172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women.
    Rosenthal D; Dyson S; Pitts M; Garland S
    Women Health; 2007; 45(2):59-73. PubMed ID: 18019286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine gardasil.
    Haupt RM; Sings HL
    J Adolesc Health; 2011 Nov; 49(5):467-75. PubMed ID: 22018560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV vaccine: a cornerstone of female health.
    Temte JL
    Am Fam Physician; 2007 Jan; 75(1):28, 30. PubMed ID: 17225700
    [No Abstract]   [Full Text] [Related]  

  • 31. [HPV vaccine and cervical cancer prevention in general practice. Survey conducted among general practitioners in the French departments of Eure-et-Loir and Cher].
    Pélissier G; Bastides F
    Rev Prat; 2008 Dec; 58(19 Suppl):25-31. PubMed ID: 19253788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acceptance of human papillomavirus vaccination among first year female university students in Hong Kong.
    Wong WC; Fong B; Chan PK
    Sex Health; 2009 Dec; 6(4):264-71. PubMed ID: 19917193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The incidence of genital warts in Australian women prior to the national vaccination program.
    Brotherton JM; Heywood A; Heley S
    Sex Health; 2009 Sep; 6(3):178-84. PubMed ID: 19653953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Singaporean women's knowledge of human papillomavirus (HPV) and attitudes toward HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Tay EH
    Women Health; 2009 Jun; 49(4):334-51. PubMed ID: 19753508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 37. Implementation of the Australian HPV vaccination program for adult women: qualitative key informant interviews.
    Leask J; Jackson C; Trevena L; McCaffery K; Brotherton J
    Vaccine; 2009 Sep; 27(40):5505-12. PubMed ID: 19619501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus (HPV) vaccines: a Canadian update.
    Foerster V; Murtagh J
    Issues Emerg Health Technol; 2007 Dec; (109):1-8. PubMed ID: 18062141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting teens and adolescents for HPV vaccine could draw fire.
    Washam C
    J Natl Cancer Inst; 2005 Jul; 97(14):1030-1. PubMed ID: 16030298
    [No Abstract]   [Full Text] [Related]  

  • 40. Moving forward: human papillomavirus vaccination and the prevention of cervical cancer.
    Vetter KM; Geller SE
    J Womens Health (Larchmt); 2007 Nov; 16(9):1258-68. PubMed ID: 18001182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.